Literature DB >> 15328030

Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate.

Khaled Radad1, Gabriele Gille, Rudolf Moldzio, Hiroshi Saito, Wolf-Dieter Rausch.   

Abstract

Ginseng, the root of Panax ginseng C.A. Meyer (Araliaceae), is a well known and popular herbal medicine used worldwide. Among more than 30 ginsenosides, the active ingredients of ginseng, ginsenosides Rb1 and Rg1 are regarded as the main compounds responsible for many pharmaceutical actions of ginseng. In our study, primary cultures from embryonic mouse mesencephala were exposed to neurotoxic glutamate concentration and potential protective effects of these two ginsenosides on survival and neuritic growth of dopaminergic cells were tested. Treatment of primary mesencephalic culture with 500 microM glutamate for 15 min on the 10th day in vitro (DIV) increased the release of lactate dehydrogenase (LDH) into the culture medium, the propidium iodide (PI) uptake by cultured cells and the total number of nuclei with condensed and fragmented chromatin (apoptotic features) as evaluated with Hoechst 33342. Moreover, it extensively decreased the number of tyrosine hydroxylase immunopositive (TH+) cells and adversely affected the length and number of their neuronal processes. The toxic effect of glutamate was primarily mediated by over-activation of N-methyl-D-aspartate receptor (NMDA) as treatment of cultured cells with (+)-MK 801, an NMDA receptor antagonist, nearly abolished dopaminergic cells loss and LDH release induced by glutamate. When either ginsenoside was added alone for six consecutive days (at final concentrations 0.1, 1, 10, 20 microM), ginsenoside Rb1 (at 10 microM) significantly enhanced the survival of dopaminergic neurons compared to untreated controls. In these cultures, neurite lengths and numbers were not affected by both ginsenosides. Against glutamate exposure, ginsenosides Rb1 and Rg1 could not prevent cell death. However when pre-treating for 4 days or post-treating for 2 days following glutamate exposure, they significantly increased the numbers and lengths of neurites of surviving dopaminergic cells. Thus our study indicates that ginsenosides Rb1 and Rg1 have a partial neurotrophic and neuroprotective role in dopaminergic cell culture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328030     DOI: 10.1016/j.brainres.2004.06.030

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  47 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons.

Authors:  Zhi-ying Lin; Li-min Chen; Jing Zhang; Xiao-dong Pan; Yuan-gui Zhu; Qin-yong Ye; Hua-pin Huang; Xiao-chun Chen
Journal:  Acta Pharmacol Sin       Date:  2012-03-12       Impact factor: 6.150

Review 3.  Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia.

Authors:  Ying Wang; Lu-qi Huang; Xi-can Tang; Hai-yan Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

4.  Effect and mechanism of panaxoside Rg1 on neovascularization in myocardial infarction rats.

Authors:  Xiao-dong Wang; Tian-xiang Gu; En-Yi Shi; Chun-mao Lu; Chun Wang
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

5.  Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1.

Authors:  Wen-Fang Chen; Wai-Sum Lau; Pik-Yuen Cheung; De-An Guo; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

6.  Effects of ginsenoside Rg-1 on the proliferation and osteogenic differentiation of human periodontal ligament stem cells.

Authors:  Li-hua Yin; Wen-xiao Cheng; Zi-shun Qin; Ke-mo Sun; Mei Zhong; Jia-kui Wang; Wei-yue Gao; Zhan-hai Yu
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

Review 7.  Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.

Authors:  Elena González-Burgos; Carlos Fernandez-Moriano; M Pilar Gómez-Serranillos
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-29       Impact factor: 4.147

8.  Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells.

Authors:  Wai-Sum Lau; Wen-Fang Chen; Robbie Yat-Kan Chan; De-An Guo; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2009-03-09       Impact factor: 8.739

Review 9.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

10.  Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway.

Authors:  Li Xu; Wen-Fang Chen; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.